<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="53" height="12" font="1">Sep 12, 2011</text>
<text top="359" left="94" width="308" height="12" font="1">Mouse monoclonal IgG, raised against recombinant Pitx1 of human origin.</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="102" height="12" font="1">fpauli@hudsonalpha.org</text>
<text top="134" left="83" width="61" height="12" font="1">Florencia Pauli</text>
<text top="215" left="121" width="74" height="12" font="1">PITX1_(SC-81979)</text>
<text top="215" left="339" width="24" height="12" font="1">PITX1</text>
<text top="170" left="230" width="25" height="12" font="1">Myers</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="485" left="361" width="28" height="12" font="1">Mouse</text>
<text top="300" left="395" width="24" height="12" font="1">J0109</text>
<text top="300" left="215" width="37" height="12" font="1">sc-81979</text>
<text top="521" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="356" width="50" height="12" font="2">Monoclonal</text>
<text top="413" left="94" width="393" height="12" font="1">This gene encodes a member of the RIEG/PITX homeobox family, which is in the bicoid class of </text>
<text top="425" left="94" width="429" height="12" font="1">homeodomain proteins.  This protein acts as a transcriptional regulator involved in basal and hormone-</text>
<text top="437" left="94" width="127" height="12" font="1">regulated activity of prolactin. </text>
<text top="449" left="94" width="121" height="12" font="1">Entrez Gene ID 5307.  39 kDa.</text>
<text top="599" left="238" width="165" height="12" font="1">http://www.scbt.com/datasheet-81979-</text>
<text top="611" left="238" width="108" height="12" font="1">pitx1-r-129-antibody.html</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="80" left="125" width="95" height="12" font="1">Western blot protocol: </text>
<text top="92" left="125" width="428" height="12" font="1">Whole cell lysate was immunoprecipitated using primary antibody, and the IP fraction was loaded on a </text>
<text top="104" left="125" width="422" height="12" font="1">12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. After separation, the samples </text>
<text top="116" left="125" width="422" height="12" font="1">were transferred to a nitrocellulose membrane with an Invitrogen iBlot system.  Blotting with primary </text>
<text top="128" left="125" width="422" height="12" font="1">(same as that used for IP) and secondary HRP-conjugated antibodies was performed on an Invitrogen </text>
<text top="140" left="125" width="414" height="12" font="1">BenchPro 4100 system. Visualization was achieved using SuperSignal West Femto solution (Thermo </text>
<text top="152" left="125" width="47" height="12" font="1">Scientific).  </text>
<text top="164" left="125" width="2" height="12" font="1"> </text>
<text top="176" left="125" width="346" height="12" font="1">Results: Band of expected size visualized, representing strongest signal in the lane.  </text>
<text top="188" left="125" width="2" height="12" font="1"> </text>
<text top="200" left="125" width="405" height="12" font="1">Figure legend: IP-western with sc-81979 in whole cell lysate (WCL) of K562 and HeLa; PM=protein </text>
<text top="212" left="125" width="135" height="12" font="1">marker. PITX1 band is indicated. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="99" left="130" width="144" height="12" font="1">IP followed by mass spectrometry: </text>
<text top="111" left="130" width="419" height="12" font="1">Briefly, K562 whole cell lysates were immunoprecipitated using primary antibody, and the IP fraction </text>
<text top="123" left="130" width="402" height="12" font="1">was loaded on a 12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. Gel was </text>
<text top="135" left="130" width="417" height="12" font="1">stained with Coomassie Blue in order to visualize marker bands. Gel fragments corresponding to the </text>
<text top="147" left="130" width="420" height="12" font="1">bands indicated above in the western blot image were excised and sent to the University of Alabama </text>
<text top="159" left="130" width="423" height="12" font="1">at Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the samples were </text>
<text top="171" left="130" width="423" height="12" font="1">run on an LTQ XL Linear Ion Trap Mass Spectrometer by LC-ESI-MS/MS. Peptides were identified using </text>
<text top="183" left="130" width="355" height="12" font="1">SEQUEST tandem mass spectra analysis, with probability based matching at p &lt; 0.05.  </text>
<text top="195" left="130" width="2" height="12" font="1"> </text>
<text top="207" left="130" width="268" height="12" font="1">As per ENCODE data standards, all SEQUEST results are attached </text>
<text top="219" left="130" width="419" height="12" font="1">(ENCODE_HAIB_PITX1_sc81979_09122011_MassSpec.pdf), including common contaminants. Target </text>
<text top="231" left="130" width="168" height="12" font="1">protein is listed as hit 7 in ~45 kDa band.</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="3" size="11" family="Times" color="#000000"/>
	<fontspec id="4" size="10" family="Times" color="#000000"/>
	<fontspec id="5" size="5" family="Times" color="#000000"/>
	<fontspec id="6" size="5" family="Times" color="#000000"/>
<text top="72" left="59" width="278" height="16" font="3"><b>Validation 2: Mass Spectrometry Analysis</b></text>
<text top="74" left="336" width="3" height="13" font="4"> </text>
<text top="98" left="59" width="503" height="13" font="4">ENCODE  data  standards  recognizes  various  methodologies  for  secondary  validation  of </text>
<text top="112" left="59" width="503" height="13" font="4">antibodies.  Among  these  methodologies  is  immunoprecipitation  followed  by  mass </text>
<text top="126" left="59" width="503" height="13" font="4">spectrometry  analysis.  Briefly,  K562  whole  cell  lysates  were  immunoprecipitated  using </text>
<text top="140" left="59" width="503" height="13" font="4">primary antibody, and the IP fraction was loaded on a 12% acrylamide gel and separated with </text>
<text top="154" left="59" width="503" height="13" font="4">a Bio-Rad PROTEAN II xi system. Gel was stained with Coomasie Blue in order to visualize </text>
<text top="167" left="59" width="503" height="13" font="4">marker bands. A gel fragment corresponding to the band indicated above in the western blot </text>
<text top="181" left="59" width="503" height="13" font="4">image was excised and sent to the University of Alabama at Birmingham Cancer Center Mass </text>
<text top="195" left="59" width="503" height="13" font="4">Spectrometry/Proteomics Shared Facility. There the sample was run on an LTQ XL Linear Ion </text>
<text top="209" left="59" width="503" height="13" font="4">Trap  Mass  Spectrometer  with  alternating  collision-induced  dissociation  and  electron-transfer </text>
<text top="223" left="59" width="503" height="13" font="4">dissociation. Peptides were identified using MASCOT (Matrix Science), with probability based </text>
<text top="236" left="59" width="503" height="13" font="4">matching  at  p  &lt;  0.05.  Subsequent  analysis  was  performed  in  Scaffold  (Proteome  Software, </text>
<text top="250" left="59" width="503" height="13" font="4">Inc.)  at  0.0%  protein  FDR  and  0.3%  peptide  FDR.  As  per  ENCODE  data  standards,  all </text>
<text top="264" left="59" width="503" height="13" font="4">Scaffold  results  are  listed  below,  including  common  contaminants.  Target  protein  is </text>
<text top="278" left="59" width="127" height="13" font="4">highlighted in bold font. </text>
<text top="302" left="59" width="3" height="13" font="4"> </text>
<text top="325" left="72" width="9" height="9" font="5">1. </text>
<text top="325" left="90" width="317" height="9" font="5">Actin, cytoplasmic 2, N-terminally processed n=9 Tax=Tetrapoda RepID=ACTG_HUMAN </text>
<text top="325" left="432" width="46" height="9" font="5">P63261 (+6) </text>
<text top="339" left="72" width="9" height="9" font="5">2. </text>
<text top="339" left="90" width="468" height="9" font="5">cDNA,  FLJ94640,  highly  similar  to  Homo  sapiens  keratin  18  (KRT18),  mRNA  n=1  Tax=Homo  sapiens  RepID=B2RA03_HUMAN</text>
<text top="353" left="90" width="2" height="9" font="5"> </text>
<text top="353" left="108" width="49" height="9" font="5">B2RA03 (+1) </text>
<text top="367" left="72" width="9" height="9" font="5">3. </text>
<text top="367" left="90" width="264" height="9" font="5">Alpha-enolase n=1 Tax=Homo sapiens RepID=ENOA_HUMAN  P06733 </text>
<text top="380" left="72" width="9" height="9" font="5">4. </text>
<text top="380" left="90" width="221" height="9" font="5">Tubulin beta chain n=12 Tax=Amniota RepID=TBB5_HUMAN </text>
<text top="380" left="324" width="30" height="9" font="5">P07437 </text>
<text top="394" left="72" width="9" height="9" font="5">5. </text>
<text top="394" left="90" width="355" height="9" font="5">Cytochrome b-c1 complex subunit 2, mitochondrial n=1 Tax=Homo sapiens RepID=QCR2_HUMAN </text>
<text top="394" left="468" width="30" height="9" font="5">P22695 </text>
<text top="408" left="72" width="9" height="9" font="5">6. </text>
<text top="408" left="90" width="256" height="9" font="5">Elongation factor 1-alpha 1 n=13 Tax=Eutheria RepID=EF1A1_HUMAN </text>
<text top="408" left="360" width="46" height="9" font="5">P68104 (+7) </text>
<text top="422" left="72" width="9" height="9" font="6"><b>7. </b></text>
<text top="422" left="90" width="300" height="9" font="6"><b>Pituitary homeobox 1 n=2 Tax=Homo sapiens RepID=PITX1_HUMAN  P78337 </b></text>
<text top="436" left="72" width="9" height="9" font="5">8. </text>
<text top="436" left="90" width="257" height="9" font="5">Phosphoglycerate kinase 1 n=3 Tax=Homininae RepID=PGK1_HUMAN </text>
<text top="436" left="360" width="46" height="9" font="5">P00558 (+1) </text>
<text top="449" left="72" width="9" height="9" font="5">9. </text>
<text top="449" left="90" width="238" height="9" font="5">52 kDa Ro protein n=1 Tax=Homo sapiens RepID=RO52_HUMAN </text>
<text top="449" left="360" width="30" height="9" font="5">P19474 </text>
<text top="463" left="72" width="274" height="9" font="5">10.  60S ribosomal protein L4 n=1 Tax=Homo sapiens RepID=RL4_HUMAN </text>
<text top="463" left="360" width="46" height="9" font="5">P36578 (+2) </text>
<text top="487" left="72" width="3" height="14" font="4">	 Â </text>
</page>
</pdf2xml>
